Mesothelioma Drug Trials

Mesothelioma Cancer News: ITT sees drop in profits after asbestos charge Mesothelioma Cancer News (press release) New York ( Mesothelioma Cancer News) – Defense and industrial manufacturing company ITT Corporation saw a substantial decrease in third quarter profits after …

NovoCure, Ltd., a privately held medical device company focused on developing the Novo-TTF device, a non-invasive portable medical device for the treatment of cancer, announced the completion of a new funding round today. Key investors in this round included Pfizer Inc, Johnson & Johnson Development Corporation and Index Ventures.